GRDX GridAI Technologies Corp. logo

GRDX GridAI Technologies Corp.

Healthcare
$4.58+0.00%OpenMarket Cap: $15.4M

As of 2026-05-26

Valuation

View Details

P/E (TTM)

PEG

P/B

0.33

P/S

448.86

EV/EBITDA

-2.67

DCF Value

$-1.68

FCF Yield

-35.0%

Div Yield

0.0%

Margins & Returns

Gross Margin

-3398.9%

Operating Margin

-19540.0%

Net Margin

-18078.3%

ROE

-11.9%

ROA

-13.3%

ROIC

-18.2%

Financials

View All
PeriodRevenueNet IncomeEPS
Q4 null$36.3K$-3.1M$
FY null$36.3K$-6.6M$
Q3 null$0.00$-1.2M$
Q2 null$0.00$-998.3K$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

1 Strong Buy0 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All
BORKOWSKI EDWARDdirector
SellThu Jan 08
Uppal Manpreetdirector
SellMon Jan 05
Pursglove Geordan Garrettdirector
SellMon Jan 05
Skowron Annaofficer: Interim CFO
SellMon Dec 29
Skowron Annaofficer
SellMon Dec 29

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

Beta

1.39

GridAI Technologies Corp. is a clinical stage biopharmaceutical company, which engages in the research and development of targeted, non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its pipeline includes Latiglutenase, Capeserod, Adrulipase, and Niclosamide. The company was founded on January 30, 2014 and is headquartered in Boca Raton, FL.

Peers